Takeover of Cynapsus Therapeutics Inc (NASDAQ:CYNA) Under Investigation for Investors
An investigation on behalf of investors, who currently hold shares of Cynapsus Therapeutics Inc (NASDAQ:CYNA), was announced concerning whether the takeover of Cynapsus Therapeutics Inc by Sunovion Pharmaceuticals Inc for $40.50 per share is unfair to NASDAQ:CYNA stockholders.
View full press release